ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05160	Hepatitis C	4/21	153/7206	0.000882329302391
ko04917	Prolactin signaling pathway	3/21	87/7206	0.00193195567489
ko04320	Dorso-ventral axis formation	2/21	31/7206	0.00357475499167
ko05215	Prostate cancer	3/21	111/7206	0.00386531143506
ko04912	GnRH signaling pathway	3/21	122/7206	0.00503995634092
ko05224	Breast cancer	3/21	174/7206	0.0133656348999
ko05213	Endometrial cancer	2/21	62/7206	0.0137694654485
ko05221	Acute myeloid leukemia	2/21	63/7206	0.0141961004905
ko05223	Non-small cell lung cancer	2/21	66/7206	0.0155102396092
ko04214	Apoptosis - fly	2/21	72/7206	0.0182895683418
ko05134	Legionellosis	2/21	74/7206	0.0192597997956
ko05214	Glioma	2/21	79/7206	0.0217787044916
ko04137	Mitophagy - animal	2/21	82/7206	0.0233527643073
ko05212	Pancreatic cancer	2/21	83/7206	0.023887714113
ko05220	Chronic myeloid leukemia	2/21	85/7206	0.0249728209446
ko04662	B cell receptor signaling pathway	2/21	88/7206	0.026638034453
ko05120	Epithelial cell signaling in Helicobacter pylori infection	2/21	92/7206	0.0289271299706
ko05132	Salmonella infection	2/21	98/7206	0.0325042955496
ko01521	EGFR tyrosine kinase inhibitor resistance	2/21	106/7206	0.0375318118981
ko04012	ErbB signaling pathway	2/21	109/7206	0.039490427114
ko04013	MAPK signaling pathway - fly	2/21	115/7206	0.0435232640112
ko04014	Ras signaling pathway	3/21	279/7206	0.045597324189
ko04066	HIF-1 signaling pathway	2/21	123/7206	0.0491313924035
ko04660	T cell receptor signaling pathway	2/21	124/7206	0.0498503618121
ko01522	Endocrine resistance	2/21	124/7206	0.0498503618121